TITLE

Interspecies data mining to predict novel ING-protein interactions in human

AUTHOR(S)
Gordon, Paul M. K.; Soliman, Mohamed A.; Bose, Pinaki; Quang Trinh; Sensen, Christoph W.; Riabowol, Karl
PUB. DATE
January 2008
SOURCE
BMC Genomics;2008, Vol. 9, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The INhibitor of Growth (ING) family of type II tumor suppressors (ING1-ING5) is involved in many cellular processes such as cell aging, apoptosis, DNA repair and tumorigenesis. To expand our understanding of the proteins with which the ING proteins interact, we designed a method that did not depend upon large-scale proteomics-based methods, since they may fail to highlight transient or relatively weak interactions. Here we test a cross-species (yeast, fly, and human) bioinformatics-based approach to identify potential human ING-interacting proteins with higher probability and accuracy than approaches based on screens in a single species. Results: We confirm the validity of this screen and show that ING1 interacts specifically with three of the three proteins tested; p38MAPK, MEKK4 and RAD50. These novel ING-interacting proteins further link ING proteins to cell stress and DNA damage signaling, providing previously unknown upstream links to DNA damage response pathways in which ING1 participates. The bioinformatics approach we describe can be used to create an interaction prediction list for any human proteins with yeast homolog(s). Conclusion: None of the validated interactions were predicted by the conventional protein-protein interaction tools we tested. Validation of our approach by traditional laboratory techniques shows that we can extract value from the voluminous weak interaction data already elucidated in yeast and fly databases. We therefore propose that the weak (low signal to noise ratio) data from large-scale interaction datasets are currently underutilized.
ACCESSION #
38123025

 

Related Articles

  • Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach. Tischkowitz, Marc; Hamel, Nancy; Carvalho, Marcelo A.; Birrane, Gabriel; Soni, Aditi; van Beers, Erik H.; Joosse, Simon A.; Wong, Nora; Novak, David; Quenneville, Louise A.; Grist, Scott A.; Nederlof, Petra M.; Goldgar, David E.; Tavtigian, Sean V.; Monteiro, Alvaro N.; Ladias, John A. A.; Foulkes, William D. // European Journal of Human Genetics;Jul2008, Vol. 16 Issue 7, p820 

    A number of germ-line mutations in the BRCA1 gene confer susceptibility to breast and ovarian cancer. However, it remains difficult to determine whether many single amino-acid (missense) changes in the BRCA1 protein that are frequently detected in the clinical setting are pathologic or not....

  • Predicted Functions of MdmX in Fine-Tuning the Response of p53 to DNA Damage. Sohyoung Kim; Aladjem, Mirit I.; McFadden, Geoffrey B.; Kohn, Kurt W. // PLoS Computational Biology;Feb2010, Vol. 6 Issue 2, p1 

    Tumor suppressor protein p53 is regulated by two structurally homologous proteins, Mdm2 and MdmX. In contrast to Mdm2, MdmX lacks ubiquitin ligase activity. Although the essential interactions of MdmX are known, it is not clear how they function to regulate p53. The regulation of tumor...

  • p53 Transactivation and the Impact of Mutations, Cofactors and Small Molecules Using a Simplified Yeast- Based Screening System. Andreotti, Virginia; Ciribilli, Yari; Monti, Paola; Bisio, Alessandra; Lion, Mattia; Jordan, Jennifer; Fronza, Gilberto; Menichini, Paola; Resnick, Michael A.; Inga, Alberto // PLoS ONE;2011, Vol. 6 Issue 6, p1 

    Background: The p53 tumor suppressor, which is altered in most cancers, is a sequence-specific transcription factor that is able to modulate the expression of many target genes and influence a variety of cellular pathways. Inactivation of the p53 pathway in cancer frequently occurs through the...

  • P53--AN ACROBAT IN TUMORIGENESIS. Moll, U. M.; Schramm, L. M. // Critical Reviews in Oral Biology & Medicine;1998, Vol. 9 Issue 1, p23 

    The p53 tumor suppressor protein plays a central role in maintaining genomic integrity. It does so by occupying a nodal point in the DNA damage control pathway. When cells are subject to ionizing radiation or other mutagenic events, p53 mediates cell cycle arrest or programmed cell death...

  • Phosphorylation of Daxx by ATM Contributes to DNA Damage-Induced p53 Activation. Tang, Jun; Agrawal, Trisha; Cheng, Qian; Qu, Like; Brewer, Michael D.; Chen, Jiandong; Yang, Xiaolu // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    p53 plays a central role in tumor suppression. It does so by inducing anti-proliferative processes as a response to various tumor-promoting stresses. p53 is regulated by the ubiquitin ligase Mdm2. The optimal function of Mdm2 requires Daxx, which stabilizes Mdm2 through the deubiquitinase...

  • Novel Strategies for Drug Discovery Based on Intrinsically Disordered Proteins (IDPs). Jihua Wang; Zanxia Cao; Liling Zhao; Shuqiang Li // International Journal of Molecular Sciences;May2011, Vol. 12 Issue 5, p3205 

    Intrinsically disordered proteins (IDPs) are proteins that usually do not adopt well-defined native structures when isolated in solution under physiological conditions. Numerous IDPs have close relationships with human diseases such as tumor, Parkinson disease, Alzheimer disease, diabetes, and...

  • Oxidative Stress Induced by MnSOD-p53 Interaction: Pro- or Anti-Tumorigenic? Robbins, Delira; Zhao, Yunfeng // Journal of Signal Transduction;2012, p1 

    The formation of reactive oxygen species (ROS) is a result of incomplete reduction of molecular oxygen during cellular metabolism. Although ROS has been shown to act as signaling molecules, it is known that these reactive molecules can act as prooxidants causing damage to DNA, proteins, and...

  • PreBIND and Textomy -- mining the biomedical literature for protein-protein interactions using a support vector machine. Donaldson, Ian; Martin, Joel; De Bruijn, Berry; Wolting, Cheryl; Lay, Vicki; Tuekam, Brigitte; Shudong Zhang; Baskin, Berivan; Bader, Gary D.; Michalickova, Katerina; Pawson, Tony; Hogue, Christopher W. V. // BMC Bioinformatics;2003, Vol. 4, p11 

    Background: The majority of experimentally verified molecular interaction and biological pathway data are present in the unstructured text of biomedical journal articles where they are inaccessible to computational methods. The Biomolecular interaction network database (BIND) seeks to capture...

  • Quantitative Fitness Analysis Shows That NMD Proteins and Many Other Protein Complexes Suppress or Enhance Distinct Telomere Cap Defects. Addinall, Stephen Gregory; Holstein, Eva-Maria; Lawless, Conor; Min Yu; Chapman, Kaye; Banks, A. Peter; Hien-Ping Ngo; Maringele, Laura; Taschuk, Morgan; Young, Alexander; Ciesiolka, Adam; Lister, Allyson Lurena; Wipat, Anil; Wilkinson, Darren James; Lydall, David // PLoS Genetics;Apr2011, Vol. 7 Issue 4, p1 

    No abstract available.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics